Lyra Health vs Calm

Side-by-side comparison of model-estimated upside.

Lyra Health

-32%

est. 2Y upside i

HealthcareSeries D+

Rank

#3413

Sector

HealthTech

Est. Liquidity

~2Y

Data Quality

Data: Medium

Given the negative expected upside (-32.4%) over 2 years, this equity grant is likely to lose value.

Last updated: July 3, 2026

Calm

-16%

est. 2Y upside i

HealthcareSeries C

Rank

#3418

Sector

Consumer Health / Wellness SaaS

Est. Liquidity

~4Y

Data Quality

Data: Medium

Calm's -24% revenue decline is a severe warning.

Last updated: March 21, 2026

Upside Comparison

Expected Upside

Lyra Health
-32%
Calm
-16%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.